Adrian Moore

4.3k total citations · 1 hit paper
78 papers, 3.2k citations indexed

About

Adrian Moore is a scholar working on Rheumatology, Molecular Biology and Immunology. According to data from OpenAlex, Adrian Moore has authored 78 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 22 papers in Molecular Biology and 20 papers in Immunology. Recurrent topics in Adrian Moore's work include Osteoarthritis Treatment and Mechanisms (25 papers), Inflammatory mediators and NSAID effects (14 papers) and Cell Adhesion Molecules Research (11 papers). Adrian Moore is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (25 papers), Inflammatory mediators and NSAID effects (14 papers) and Cell Adhesion Molecules Research (11 papers). Adrian Moore collaborates with scholars based in United Kingdom, United States and Russia. Adrian Moore's co-authors include D. A. Willoughby, Dean Willis, Ronnie O. Frederick, Paul Colville‐Nash, D. A. Willoughby, Derek W. Gilroy, Kevin Greenslade, Martyn K. Robinson, Massimo Marenzana and Mauro Perretti and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Adrian Moore

78 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heme oxygenase: A novel target for the modulation of inflammatory response

1996 671 citations Dean Willis, Adrian Moore et al. profile →

Peers

Countries citing papers authored by Adrian Moore

Since Specialization

Citations

This map shows the geographic impact of Adrian Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Moore more than expected).

Fields of papers citing papers by Adrian Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Moore. The network helps show where Adrian Moore may publish in the future.

Co-authorship network of co-authors of Adrian Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Moore. A scholar is included among the top collaborators of Adrian Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Moore. Adrian Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neutrophil Microvesicles from Healthy Control and Rheumatoid Arthritis Patients Prevent the Inflammatory Activation of Macrophages 2018 ·EBioMedicine ·Hefin Rhys, Francesco Dell’Accio, Costantino Pitzalis, Adrian Moore, Lucy V. Norling, Mauro Perretti	90
2	Identification of Novel Chondroprotective Mediators in Resolving Inflammatory Exudates 2017 ·The Journal of Immunology ·(unknown), Karin Vicente Greco, Sarah E. Headland, Trinidad Montero‐Melendez, (unknown), Kevin Greenslade, Costantino Pitzalis, Adrian Moore, Mauro Perretti	8
3	A modified and enhanced atdc5 chondrogenesis model produces an articular-like phenotype 2014 ·Osteoarthritis and Cartilage ·(unknown), Lara Kevorkian, T.E. Swingler, (unknown), Colin Stubberfield, Adrian Moore, Jelena Gavrilović	2
4	An overview of cancer treatments 2009 ·Pharmaceutical journal/The pharmaceutical journal ·(unknown), Paul W. Groundwater, Adam Todd, Adrian Moore	4
5	Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis 2009 ·Journal of Immunological Methods ·Roger Palframan, (unknown), Adrian Moore, (unknown), Andrew Nesbitt	99
6	An Hypothesis to Link the Opposing Immunological Effects Induced by the Bacterial Lysate OM-89 in Urinary Tract Infection and Rheumatoid Arthritis 2006 ·BioDrugs ·Carlo Chiavaroli, Adrian Moore	15
7	Prostaglandin F2α produced by inducible cyclooxygenase may contribute to the resolution of inflammation 2005 ·Inflammopharmacology ·Paul Colville‐Nash, Derek W. Gilroy, Dean Willis, Mark J. Paul‐Clark, Adrian Moore, D. A. Willoughby	13
8	Pleural Models of Inflammation Immune and Nonimmune 2003 ·Humana Press eBooks ·Adrian Moore	29
9	Collagen-Induced Arthritis 2003 ·Humana Press eBooks ·Adrian Moore	8
10	Destruction of articular cartilage by alpha2macroglobulin elastase complexes: role in rheumatoid arthritis 1999 ·Annals of the Rheumatic Diseases ·Adrian Moore, (unknown), Kazuhito Kawabata, José António Pereira da Silva, David D’Cruz, G. Gowland, D. A. Willoughby	27
11	Effects of diacerhein on granuloma induced cartilage breakdown in the mouse 1998 ·Osteoarthritis and Cartilage ·Adrian Moore, Kevin Greenslade, (unknown), D. A. Willoughby	55
12	Specific Antibodies to Om-89 Can Account for its Clinical Anti-Inflammatory Properties 1998 ·International Journal of Immunopathology and Pharmacology ·(unknown), Adrian Moore, G. Gowland, D. A. Willoughby	2
13	Additional comments on non-steroidal anti-inflammatory drugs and topical analgesia ( PAIN , 61 (1995) 494–495) 1996 ·Pain ·D. A. Willoughby, (unknown), Adrian Moore, Michael Seed	1
14	Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. 1995 ·PubMed ·Adrian Moore, D. A. Willoughby	48
15	OM-89 MODULATION OF CHRONIC INFLAMMATION: RELEVANCE TO CLINICAL USE 1995 ·Lara D. Veeken ·Dean Willis, Adrian Moore, G. Gowland, D. A. Willoughby	5
16	POLYARTHRITIS IN THE RAT: EFFECTS OF TOLERANCE AND SENSITIZATION TO THE BACTERIAL EXTRACT OM-89 WITH A POSSIBLE MODE OF ACTION 1995 ·Lara D. Veeken ·Dean Willis, Adrian Moore, G. Gowland, D. A. Willoughby	9
17	Coronary vasoconstriction in vitro in the hearts of polyarthritic rats: effectiveness of in vivo treatment with the endothelin receptor antagonist SB 209670 1995 ·British Journal of Pharmacology ·Timothy D. Warner, Dean Willis, Adrian Moore, John R. Vane, Peter Klemm	5
18	Comparison of endothelin-1 and-3 on models of inflammation 1990 ·Inflammation Research ·C. L. Chander, D. Howat, Adrian Moore, Paul Colville‐Nash, (unknown), P. Braquet, D. A. Willoughby	8
19	Anti-Inflammatory Effects of Endothelin-1 1989 ·Journal of Cardiovascular Pharmacology ·C. L. Chander, Adrian Moore, (unknown), D. Howat, D. A. Willoughby	12
20	Connective tissue abnormalities in MRL/1 mice. 1986 ·Annals of the Rheumatic Diseases ·Jo C. W. Edwards, Anne Cooke, Adrian Moore, C Collins, F C Hay, D. A. Willoughby	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact